Debt to Equity Ratio Chart

View Debt to Equity Ratio for HLSQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 0.3022
March 31, 2026 0.00
December 31, 2025 -1.103
September 30, 2025 0.6278
June 30, 2025 0.4894
March 31, 2025 0.3793
December 31, 2024 0.3969
September 30, 2024 0.2572
June 30, 2024 0.3608
March 31, 2024 0.4426
December 31, 2023 4.898
September 30, 2023 1.988
June 30, 2023 1.109
March 31, 2023 1.163
December 31, 2022 0.9201
September 30, 2022 0.7289
Date Value
June 30, 2022 0.5928
March 31, 2022 0.4972
December 31, 2021 0.4211
September 30, 2021 0.3697
June 30, 2021 0.1167
March 31, 2021 0.102
December 31, 2020 0.1026
September 30, 2020 0.0683
June 30, 2020 0.0141
March 31, 2020 0.0139
December 31, 2019 0.0146
September 30, 2019 0.033
June 30, 2019
March 31, 2019 0.00
December 31, 2018 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agenus, Inc. -1.458
Amgen, Inc. 4.903
Anika Therapeutics, Inc. 0.1839
BioCryst Pharmaceuticals, Inc. -1.842
Imunon, Inc. 1.873